Cargando…
Long Non-Coding RNAs in Drug Resistance of Breast Cancer
Breast cancer (BC) is the most common cancer and the leading cause of death in women. Advances in early diagnosis and therapeutic strategies have decreased the mortality of BC and improved the prognosis of patients to some extent. However, the development of drug resistance has limited the success r...
Autores principales: | Du, Tonghua, Shi, Ying, Xu, Shengnan, Wan, Xiaoyu, Sun, Haiyin, Liu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382578/ https://www.ncbi.nlm.nih.gov/pubmed/32764993 http://dx.doi.org/10.2147/OTT.S255226 |
Ejemplares similares
-
The Role of Non-Coding RNAs in Breast Cancer Drug Resistance
por: Tian, Jin-hai, et al.
Publicado: (2021) -
Long non-coding RNAs in anti-cancer drug resistance
por: Chen, Qin-nan, et al.
Publicado: (2016) -
Long non-coding RNAs regulate drug resistance in cancer
por: Liu, Kaisheng, et al.
Publicado: (2020) -
The role of exosomal long non-coding RNAs in cancer drug resistance
por: Cruz De los Santos, Mireia, et al.
Publicado: (2019) -
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
por: Wei, Ling, et al.
Publicado: (2021)